Primary cutaneous CD30+ anaplastic large-cell lymphoma associated with fingolimod

Br J Dermatol. 2018 Dec;179(6):1400-1401. doi: 10.1111/bjd.17003. Epub 2018 Oct 10.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Biopsy
  • Female
  • Fingolimod Hydrochloride / adverse effects*
  • Humans
  • Immunosuppressive Agents / adverse effects*
  • Ki-1 Antigen / metabolism
  • Lymphoma, Large-Cell, Anaplastic / chemically induced*
  • Lymphoma, Large-Cell, Anaplastic / diagnosis
  • Lymphoma, Large-Cell, Anaplastic / pathology
  • Middle Aged
  • Multiple Sclerosis, Relapsing-Remitting / drug therapy*
  • Receptors, Lysosphingolipid / antagonists & inhibitors
  • Receptors, Lysosphingolipid / metabolism
  • Skin / cytology
  • Skin / drug effects
  • Skin / pathology
  • Skin Neoplasms / chemically induced*
  • Skin Neoplasms / diagnosis
  • Skin Neoplasms / pathology
  • T-Lymphocytes / drug effects
  • T-Lymphocytes / metabolism

Substances

  • Immunosuppressive Agents
  • Ki-1 Antigen
  • Receptors, Lysosphingolipid
  • Fingolimod Hydrochloride